ScreenerHero
VIAViatris Inc.
XETRA · DE · Healthcare · Drug Manufacturers - Specialty & Generic · viatris.com
13.84EUR-1.56%Mkt Cap: 17.28B $P/E: —

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap17.28B $
Enterprise Value30.82B $
Revenue (TTM)16.02B $
Gross Profit5.45B $
Net Income (TTM)-3.82B $
Revenue/Share13.82 USD
Last Price13.84 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees30.0K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS92556V1061
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG1.06
EV/EBITDA6.61
EV/Revenue1.92
P/S1.10
P/B1.28
EPS (TTM)-0.32
EPS (Forward)—
52W Range
13.7617% of range14.21
52W High14.21 EUR
52W Low13.76 EUR
Profitability
Gross Margin35.06%
Oper. Margin12.55%
EBITDA Margin29.13%
Profit Margin-24.58%
ROE-23.89%
ROA-9.45%
Growth
Revenue Growth4.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.52B $
CapEx (TTM)505.54M $
FCF Margin18.17%
FCF Yield16.84%
Net Debt13.17B $
Net Debt/EBITDA2.82
Balance Sheet
Debt/Equity1.00
Current Ratio1.58
Quick Ratio0.82
Book Value/Sh11.02 EUR
Cash/Share1.315 EUR
Dividends
Fwd Div Rate0.4200 EUR
Trail. Div Rate0.4800 EUR
Div. Yield2.98%
5Y Avg Yield4.08%
Payout Ratio960.00%
Ex-Div DateAug 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.15B
Float1.14B
Insiders0.32%
Institutions93.28%
Technical
SMA 5014.47 (-4.4%)
SMA 20012.43 (+11.4%)
Beta0.89
S&P 52W Chg20.80%
Avg Vol (30d)1.07K
Avg Vol (10d)5.06K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—